Incyte End Period Cash Flow from 2010 to 2024
| INCY Stock | USD 54.06 0.30 0.56% |
End Period Cash Flow | First Reported 1993-12-31 | Previous Quarter 3.2 B | Current Value 3.3 B | Quarterly Volatility 827 M |
Check Incyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incyte main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.8 M, Interest Expense of 2.4 M or Total Revenue of 3.9 B, as well as many exotic indicators such as Price To Sales Ratio of 3.61, Dividend Yield of 0.0 or PTB Ratio of 2.84. Incyte financial statements analysis is a perfect complement when working with Incyte Valuation or Volatility modules.
Incyte | End Period Cash Flow |
Latest Incyte's End Period Cash Flow Growth Pattern
Below is the plot of the End Period Cash Flow of Incyte over the last few years. It is Incyte's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incyte's overall financial position and show how it may be relating to other accounts over time.
| End Period Cash Flow | 10 Years Trend |
|
End Period Cash Flow |
| Timeline |
Incyte End Period Cash Flow Regression Statistics
| Arithmetic Mean | 1,308,725,270 | |
| Geometric Mean | 761,535,383 | |
| Coefficient Of Variation | 86.83 | |
| Mean Deviation | 946,613,791 | |
| Median | 899,509,000 | |
| Standard Deviation | 1,136,325,856 | |
| Sample Variance | 1291236.5T | |
| Range | 3.4B | |
| R-Value | 0.95 | |
| Mean Square Error | 140063.8T | |
| R-Squared | 0.90 | |
| Slope | 240,954,066 | |
| Total Sum of Squares | 18077310.3T |
Incyte End Period Cash Flow History
About Incyte Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Incyte income statement, its balance sheet, and the statement of cash flows. Incyte investors use historical funamental indicators, such as Incyte's End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Incyte investors may use each financial statement separately, they are all related. The changes in Incyte's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Incyte's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Incyte Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Incyte. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| End Period Cash Flow | 3.2 B | 3.4 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Incyte Correlation against competitors. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Incyte Stock analysis
When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.705 | Earnings Share 3.3 | Revenue Per Share 16.82 | Quarterly Revenue Growth 0.089 | Return On Assets 0.0689 |
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.